What dose of intravenous metoprolol should be given to an adult with a sustained heart rate >110 bpm, hemodynamic stability, systolic blood pressure ≥90 mmHg, and no contraindications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Metoprolol Dosing for Acute Tachycardia

Administer 5 mg of intravenous metoprolol over 1 to 2 minutes, and repeat every 5 minutes as needed up to a maximum total dose of 15 mg. 111111

Dosing Protocol

The standard approach for IV metoprolol in hemodynamically stable adults with sustained tachycardia >110 bpm is:

  • Initial dose: 5 mg IV push over 1-2 minutes
  • Repeat dosing: Additional 5 mg boluses every 5 minutes if needed
  • Maximum total dose: 15 mg (three 5 mg doses)

This dosing regimen is consistently recommended across multiple American Heart Association ACLS guidelines 111111, the ACC/AHA/HRS SVT guidelines 2, the ACC/AHA/HRS atrial fibrillation guidelines 3, and FDA labeling 4.

Clinical Context

Beta-1 selective blockers like metoprolol are indicated for:

  • Stable narrow-complex tachycardias uncontrolled by adenosine or vagal maneuvers
  • Rate control in atrial fibrillation or atrial flutter
  • Recurrent SVT 111

The 5 mg incremental dosing allows for titration based on response while monitoring for adverse effects. In clinical studies, mean doses of approximately 9.5 mg (range 2-15 mg) achieved rate control in 81% of patients with supraventricular tachyarrhythmias, reducing ventricular rate from 134 to 106 bpm within 10 minutes 5.

Monitoring Requirements

During administration, continuously monitor:

  • Blood pressure (watch for hypotension <90 mmHg systolic)
  • Heart rate (watch for excessive bradycardia <60 bpm)
  • Electrocardiogram
  • Hemodynamic stability 4

Hypotension occurred in approximately 10% of patients in clinical trials but was typically transient and manageable 56. The drug should be administered in a setting with intensive monitoring capabilities 4.

Contraindications to Verify

Do not administer if patient has:

  • Decompensated heart failure
  • Second- or third-degree heart block (without pacemaker)
  • Severe bradycardia
  • Reactive airway disease or severe COPD with bronchospasm
  • Pre-excited atrial fibrillation/flutter (WPW syndrome) 1117

Comparative Efficacy

While diltiazem demonstrates superior rate control achievement compared to metoprolol (61% vs 44% achieving rate <110 bpm) 86, metoprolol remains an appropriate first-line agent, particularly when beta-blockade is specifically desired or calcium channel blockers are contraindicated. Both agents show similar safety profiles regarding hypotension and bradycardia 86.

The 5 mg incremental dosing strategy allows for individualized titration while maintaining safety, with most patients tolerating the full 15 mg dose (85% in large community practice studies) 9.

References

Guideline

esc council on hypertension position document on the management of hypertensive emergencies.

European Heart Journal - Cardiovascular Pharmacotherapy, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.